Eleonora Cioli

Naples, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications

HER-2 gene alterations as biomarker in patients with metastatic colorectal cancer treated with FOLFIRI + cetuximab: findings from the CAPRI-2 GOIM study.

HER-2 gene alterations as biomarker in patients with metastatic colorectal cancer treated with FOLFIRI + cetuximab: findings from the CAPRI-2 GOIM study.

Journal: ESMO gastrointestinal oncology
Published: April 17, 2026

Adjuvant immunotherapy in high-risk stage II melanoma: real-world outcomes from a large multicenter retrospective study.

Adjuvant immunotherapy in high-risk stage II melanoma: real-world outcomes from a large multicenter retrospective study.

Journal: Cancer immunology, immunotherapy : CII
Published: April 08, 2026

Management of cancer-associated thrombosis in patients with gastrointestinal cancers: lights and shadows.

Management of cancer-associated thrombosis in patients with gastrointestinal cancers: lights and shadows.

Journal: Cancer treatment reviews
Published: February 08, 2026

Off-label drug use in oncology: integrating molecular and genetic analysis in an academic center's real-world approach.

Off-label drug use in oncology: integrating molecular and genetic analysis in an academic center's real-world approach.

Journal: ESMO real world data and digital oncology
Published: February 06, 2026

Clinical activity and safety of nivolumab in combination with ipilimumab in metastatic melanoma: findings from REALIPINIVO, a real-world study.

Clinical activity and safety of nivolumab in combination with ipilimumab in metastatic melanoma: findings from REALIPINIVO, a real-world study.

Journal: Frontiers in immunology
Published: November 03, 2025

Integrating tissue and liquid biopsy comprehensive genomic profiling to predict efficacy of anti-EGFR therapies in metastatic colorectal cancer: Findings from the CAPRI-2 GOIM study.

Integrating tissue and liquid biopsy comprehensive genomic profiling to predict efficacy of anti-EGFR therapies in metastatic colorectal cancer: Findings from the CAPRI-2 GOIM study.

Journal: European journal of cancer (Oxford, England : 1990)
Published: April 13, 2025

Systemic Therapies for Advanced Hepatocellular Carcinoma: Which Gaps Should We Try to Fill?

Systemic Therapies for Advanced Hepatocellular Carcinoma: Which Gaps Should We Try to Fill?

Journal: JCO oncology practice
Published: April 11, 2025

BRAFV600E mutant metastatic colorectal cancer: Current advances in personalized treatment and future perspectives.

BRAFV600E mutant metastatic colorectal cancer: Current advances in personalized treatment and future perspectives.

Journal: Cancer treatment reviews
Published: January 25, 2025

Comprehensive genomic profiling by liquid biopsy portrays metastatic colorectal cancer mutational landscape to predict antitumor efficacy of FOLFIRI plus cetuximab in the CAPRI-2 GOIM trial.

Comprehensive genomic profiling by liquid biopsy portrays metastatic colorectal cancer mutational landscape to predict antitumor efficacy of FOLFIRI plus cetuximab in the CAPRI-2 GOIM trial.

Journal: ESMO open
Published: January 20, 2025

Overexpression of CCL-20 and CXCL-8 genes enhances tumor escape and resistance to cemiplimab, a programmed cell death protein-1 (PD-1) inhibitor, in patients with locally advanced and metastatic cutaneous squamous cell carcinoma.

Overexpression of CCL-20 and CXCL-8 genes enhances tumor escape and resistance to cemiplimab, a programmed cell death protein-1 (PD-1) inhibitor, in patients with locally advanced and metastatic cutaneous squamous cell carcinoma.

Journal: Oncoimmunology
Published: August 29, 2024

PARP inhibitors in testicular germ cell tumors: what we know and what we are looking for.

PARP inhibitors in testicular germ cell tumors: what we know and what we are looking for.

Journal: Frontiers in genetics
Published: August 13, 2024

Impact of cemiplimab treatment duration on clinical outcomes in advanced cutaneous squamous cell carcinoma.

Impact of cemiplimab treatment duration on clinical outcomes in advanced cutaneous squamous cell carcinoma.

Journal: Cancer immunology, immunotherapy : CII
Published: February 29, 2024
Showing 1-12 of 15

Last Updated: 09/26/2026